[1]
“‘To Study The Association Of Leptin As A Predictive Marker In Obese And Non-Obese Women With Polycystic Ovary Syndrome Patients.’”, Journal of Pharmaceutical Negative Results, pp. 3930–3940, Dec. 2022, Accessed: Jun. 30, 2026. [Online]. Available: https://pnrjournal.com/index.php/home/article/view/5687